
Ken Weixing Ho
Advertisement
Articles by Ken Weixing Ho

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Pertuzumab Biosimilar in HER2+ Breast Cancer
2
FDA Provides CRL to Ivonescimab/Chemotherapy for Pretreated EGFR+ NSCLC
3
FDA Approves Giredestrant/Everolimus for ER+, HER2–, ESR1-Mutated Breast Cancer
4
Cretostimogene Cuts Recurrence Risk in Intermediate-Risk, High-Grade Ta NMIBC
5
